About Marinus Pharma
Marinus Pharma is a company based in Radnor (United States) founded in 2003 was acquired by Immedica in December 2024.. Marinus Pharma has raised $71.58 million across 5 funding rounds from investors including Canaan, Immedica and Southern New Hampshire Health. Marinus Pharma offers products and services including Ganaxolone. Marinus Pharma operates in a competitive market with competitors including Arvelle Therapeutics, ORPHELIA Pharma, Corlieve Therapeutics, EpilepsyGTx and GenEp, among others.
- Headquarter Radnor, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Marinus Pharmaceuticals, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Marinus Pharma
Marinus Pharma offers a comprehensive portfolio of products and services, including Ganaxolone. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medication for treating severe epilepsy and seizure disorders.
Unlock access to complete
Unlock access to complete
Funding Insights of Marinus Pharma
Marinus Pharma has successfully raised a total of $71.58M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.23 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $1.2M
-
First Round
First Round
(25 Oct 2005)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Post-IPO - Marinus Pharma | Valuation |
investors |
|
| Dec, 2019 | Amount | Post-IPO - Marinus Pharma | Valuation |
investors |
|
| Jul, 2013 | Amount | Series C - Marinus Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Marinus Pharma
Marinus Pharma has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Canaan, Immedica and Southern New Hampshire Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Healthcare investments are managed by corporate-backed venture capital fund RusnanoMedInvest.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Marinus Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Marinus Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Marinus Pharma Comparisons
Competitors of Marinus Pharma
Marinus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arvelle Therapeutics, ORPHELIA Pharma, Corlieve Therapeutics, EpilepsyGTx and GenEp, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapies are developed for partial-onset seizures treatment.
|
|
| domain | founded_year | HQ Location |
Therapies for pediatric neurology, oncology, and hematology are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurological disorders are developed using AAV gene delivery.
|
|
| domain | founded_year | HQ Location |
Gene therapies for focal refractory epilepsy are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for epilepsy are developed targeting ion channel mutations.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Marinus Pharma
Frequently Asked Questions about Marinus Pharma
When was Marinus Pharma founded?
Marinus Pharma was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Where is Marinus Pharma located?
Marinus Pharma is headquartered in Radnor, United States. It is registered at Radnor, Pennsylvania, United States.
Is Marinus Pharma a funded company?
Marinus Pharma is a funded company, having raised a total of $71.58M across 5 funding rounds to date. The company's 1st funding round was a Series C of $21.77M, raised on Oct 25, 2005.
What does Marinus Pharma do?
Founded in 2003, Marinus Pharma is based in Radnor, United States, where pharmaceuticals targeting seizure disorders are developed. The lead product, Ganaxolone, is provided in intravenous and oral forms for addressing status epilepticus and rare orphan epilepsies. Operations encompass drug development within the neurology sector, alongside advocacy and associated initiatives.
Who are the top competitors of Marinus Pharma?
Marinus Pharma's top competitors include Arvelle Therapeutics, ORPHELIA Pharma and Corlieve Therapeutics.
What products or services does Marinus Pharma offer?
Marinus Pharma offers Ganaxolone.
Who are Marinus Pharma's investors?
Marinus Pharma has 7 investors. Key investors include Canaan, Immedica, Southern New Hampshire Health, Sofinnova, and RusnanoMedInvest.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.